Cargando…
Is APC hypermethylation a diagnostic biomarker for bladder cancer? A meta-analysis
OBJECTIVE: Numerous studies have been performed to investigate the association between APC promoter hypermethylation and bladder cancer risk. Nevertheless, the conclusion was uncertain due to small sample size, different ethnicities, and tumor subtype. Hence, to accurately assess the effect of APC p...
Autores principales: | Han, Wei, Wang, Yutao, Fan, Jingli, Wang, Chunlei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267632/ https://www.ncbi.nlm.nih.gov/pubmed/30568459 http://dx.doi.org/10.2147/OTT.S177601 |
Ejemplares similares
-
Early diagnostic potential of APC hypermethylation in esophageal cancer
por: Wang, Bujiang, et al.
Publicado: (2018) -
Hypermethylation of APC2 Is a Predictive Epigenetic Biomarker for Chinese Colorectal Cancer
por: He, Yuan, et al.
Publicado: (2018) -
Hypermethylated APC in serous carcinoma based on a meta-analysis of ovarian cancer
por: Shen, Chunyan, et al.
Publicado: (2016) -
APC hypermethylation for early diagnosis of colorectal cancer: a meta-analysis and literature review
por: Liang, Tie-Jun, et al.
Publicado: (2017) -
APC Promoter Hypermethylation as a Prognostic Marker in Breast Cancer Patients
por: Saelee, Pensri, et al.
Publicado: (2020)